PRATI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 24.274
AS - Asia 11.115
EU - Europa 10.453
SA - Sud America 1.532
Continente sconosciuto - Info sul continente non disponibili 197
AF - Africa 190
OC - Oceania 25
Totale 47.786
Nazione #
US - Stati Uniti d'America 23.646
SG - Singapore 3.416
CN - Cina 3.121
IT - Italia 2.959
GB - Regno Unito 2.574
SE - Svezia 1.378
VN - Vietnam 1.307
HK - Hong Kong 1.173
BR - Brasile 1.153
DE - Germania 786
UA - Ucraina 522
RU - Federazione Russa 478
FR - Francia 442
FI - Finlandia 406
TR - Turchia 398
BD - Bangladesh 385
KR - Corea 360
CA - Canada 296
IN - India 225
BG - Bulgaria 180
NL - Olanda 164
MX - Messico 122
JP - Giappone 115
AR - Argentina 112
ID - Indonesia 106
IQ - Iraq 92
PL - Polonia 85
ES - Italia 79
BE - Belgio 76
IE - Irlanda 74
EC - Ecuador 63
CO - Colombia 59
ZA - Sudafrica 54
LT - Lituania 51
PK - Pakistan 51
UZ - Uzbekistan 40
RO - Romania 39
AE - Emirati Arabi Uniti 37
CL - Cile 34
CR - Costa Rica 33
MA - Marocco 32
CH - Svizzera 31
JM - Giamaica 31
VE - Venezuela 31
AT - Austria 30
PE - Perù 28
HN - Honduras 26
PH - Filippine 26
MY - Malesia 25
JO - Giordania 23
IL - Israele 22
SA - Arabia Saudita 21
AZ - Azerbaigian 20
GT - Guatemala 20
TH - Thailandia 20
AU - Australia 19
KZ - Kazakistan 19
NP - Nepal 19
SV - El Salvador 19
NI - Nicaragua 18
TN - Tunisia 18
EE - Estonia 17
PY - Paraguay 17
BO - Bolivia 16
KE - Kenya 16
IR - Iran 15
TW - Taiwan 15
UY - Uruguay 14
EG - Egitto 13
ET - Etiopia 13
PR - Porto Rico 13
TT - Trinidad e Tobago 12
CZ - Repubblica Ceca 11
DZ - Algeria 11
MD - Moldavia 11
OM - Oman 11
PT - Portogallo 10
GP - Guadalupe 9
LB - Libano 8
PA - Panama 8
SC - Seychelles 8
AL - Albania 7
CW - ???statistics.table.value.countryCode.CW??? 7
EU - Europa 7
QA - Qatar 7
BH - Bahrain 6
DO - Repubblica Dominicana 6
GR - Grecia 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
SN - Senegal 6
CI - Costa d'Avorio 5
HU - Ungheria 5
RS - Serbia 5
DK - Danimarca 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 47.539
Città #
Ashburn 3.067
Santa Clara 2.158
Singapore 2.105
Southend 1.634
Chandler 1.384
Fairfield 1.360
Hefei 1.200
Woodbridge 1.164
Hong Kong 1.146
San Jose 1.051
Jacksonville 960
Houston 861
Council Bluffs 850
Dearborn 738
Nyköping 687
Ann Arbor 676
Beijing 537
Wilmington 522
Seattle 510
Cambridge 479
London 473
Los Angeles 415
Ho Chi Minh City 391
Seoul 327
Hanoi 318
The Dalles 287
Modena 269
New York 261
Milan 253
Chicago 244
Helsinki 237
Des Moines 211
Dallas 198
Princeton 194
Izmir 189
Sofia 172
San Diego 157
Eugene 154
Lauterbourg 143
Buffalo 139
São Paulo 139
Washington 137
Shanghai 136
Berlin 109
Redwood City 106
Rome 102
Orem 96
Moscow 95
Phoenix 77
Tokyo 75
Columbus 74
Warsaw 72
Salt Lake City 70
Atlanta 68
Bologna 64
Brooklyn 64
Boardman 63
Da Nang 63
Denver 63
Toronto 63
Dublin 62
Fremont 62
Munich 60
Montreal 58
Chennai 54
Reggio Emilia 54
Frankfurt am Main 53
Brussels 52
Jakarta 52
Bremen 46
Haiphong 46
Guangzhou 45
Amsterdam 43
Mexico City 43
Kunming 42
Kent 41
Tampa 41
Yalova 41
Elk Grove Village 39
Naples 38
Parma 36
Tashkent 36
Florence 35
Boston 34
Rio de Janeiro 34
Manchester 33
Baghdad 32
Falls Church 31
Johannesburg 30
Miano 30
Norwalk 30
San Francisco 29
Vancouver 29
Turin 28
Belo Horizonte 27
Norfolk 27
Stockholm 27
Austin 25
Redondo Beach 25
San José 25
Totale 31.432
Nome #
Sintesi di alogenuri vinilici e gem-dialogenuri da aldeidi e chetoni 1.055
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 919
A Mild Synthesis of Vinyl Halides and gem-Dihalides Using Triphenyl Phosphite–Halogen-based Reagents 496
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 437
Sintesi di Nitrili da Ammidi: Degradazione di Von Braun in Condizioni Blande 422
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 419
Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors 413
Chemo-enzymatic synthesis of levodropropizine 413
A mild synthesis of nitriles by von Braun degradation of amides using triphenyl phosphite-halogen-based reagents 410
Effetto del Bromuro di Allile e dell'Alcool Allilico nella Riduzione con Lievito di Composti Carbonilici alfa-Alogenati 404
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 396
Isolation, structure elucidation and total synthesis of a cytotoxic dienone from Echinacea pallida 394
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 387
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 379
(R)-(+) and (S)-(-) ethyl 4,4,4-trifluoro-3-hydroxy butanoate by enantioselective Baker's yeast reduction 374
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 369
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 366
Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography 360
An Easy Route to Enantiomerically Enriched 7- and 8-Hydroxy-stearic Acids by Olefin-Metathesis-Based Approach 353
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 351
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 350
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 349
Chimica Organica 348
A novel approach to a precursor of the carbapenem antibiotic PS-5 via aziridine stereospecific carbonylation 345
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 344
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 343
Enantioselective total synthesis of (-)-microcarpalide 340
A very mild access to 3,4-dihydroisoquinolines using triphenyl phosphite-bromine-mediated Bischler-Napieralski-type cyclization 337
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 334
Alkene Metathesis in Organic Synthesis 331
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 331
A mild synthesis of nitriles by TPPX2-promoted dehydration of primary amides 330
Nanomolar inhibitors of AmpC beta-lactamase 329
Optimizing Cell Permeation of an Antibiotic Resistance Inhibitor for Improved Efficacy 329
Catalisi Enzimatica nella Sintesi di Prodotti Fluorurati Chirali 328
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 328
Enzymatic Resolution of Chiral N-Alkyloxaziridine-3,3-dicarboxylic Esters 327
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 326
'Ligand-free-like' CuCl-catalyzed atom transfer radical cyclization of N-substituted N-allyl polychloroamides to γ-lactams. 326
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 326
Candida Cylindracea Lipase Catalysed Hydrolysis of Methyl Aziridine 2-Carboxylates and 2,3-Dicarboxylates. 323
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 323
Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria 320
The triphenyl phosphite-chlorine reagent in the synthesis of pyrroles from N-allylamides 318
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 318
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 315
Biotransformations of Fluorinated Sulphenyl and Sulphonyl Compounds 311
Partecipazione a Spin Off 311
Synthesis, characterization and metal coordination of a potential β-lactamase inhibitor: 5-Methyl-2-phenoxymethyl-3-H-imidazole-4-carboxylic acid (PIMA) 310
Total synthesis of )-microcarpalide, a novel microfilament disrupting metabolite 308
Paternó-Büchi reaction versus hydrogen abstraction in the photochemical reactivity of alkenyl boronates with benzophenone 308
Novel Insights into the mode of inhibition of class A SHV-1 β-lactamase revealed by boronic acid transition state inhibitors 305
Derivatives of Optically Active 1-Chloro-2,2-bismethoxycarbonylaziridine: Absolute Configuration and X-Ray Molecular Structure of (-)-(E)-1-Chloro-2- methoxycarbonyl- 2-methylcarbamoylaziridine. 303
Enzymatic Resolution of Aziridine-Carboxylates 302
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 302
A Chemoenzymatic Approach to beta-Lactams from Hydroxymethyl Aziridines 299
Applications of the (PhO)(3)PCl2 reagent: A new protocol for mild cleavage of sulfinamides and sulfonamides 295
Electron and electrospray ionization mass spectrometry in the characterization of some 1-allyl-3-phenylaziridines 290
alpha- and beta-Aminoacids from Optically-Active Aziridine-2-Carboxylates 290
Enantioselective Synthesis of (S)-(Ð)-5,5,5-Trifluoro-4-Hydroxy-2-Pentanone by Baker's Yeast Reduction. 288
Biotrasformazioni di Composti Fluorurati 287
Total synthesis of a dienynone from Echinacea pallida 287
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 286
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 285
Sintesi Stereospecifiche di beta-Lattami da Aziridine 285
Isolation, structure elucidation, synthesis and cytotoxic activity of polyacetylenes and polyenes from Echinacea pallida 284
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 284
Synthesis of N-bridgehead fused bicyclic beta-lactams through organometal-mediated transformations of 1,2-dialkenylaziridines 283
Chiroptical Properties of (S)-(-) Methyl Glycolate-d1 281
Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin binding protein 281
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 280
Enzymatic Resolution of Aziridine- and Oxaziridine-Carboxylates 278
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 277
Approcci sintetici alla 6-epi-decarestrictina C1 277
Sintesi Asimmetrica Biocatalitica di (S)-(–)-Timolo 276
Low-temperature deacylation of N-monosubstituted amides 275
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 274
Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors 274
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 274
Isolation, structure elucidation, synthesis and cytotoxic activity of polyacetylenes and polyenes from Echinacea pallida 271
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 269
Optically Active cis- and trans-1-Chloro-2-methoxycarbonyl-2-methylcarbamoyl-aziridines. Stereochemical Properties 268
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 267
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 266
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 266
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 264
An efficient and versatile synthesis of new Trojan-horse cephalosporins 263
alpha- and beta-Aminoacids from Optically-Active Aziridine-2-Carboxylates 263
Optically Active α-Phenylethylamine as Efficient Organocatalyst in the Solvent-free Reactions Between 2,3-Butanedione and Conjugated Nitroolefins 261
Chiroptical Properties of (S)-(-) Methyl Glycolate 260
Microbial Synthesis and Absolute Configuration of Methyl (+) and (-) 4-Chloro-4,4-difluoro-3-hydroxybutanoate. 259
Chimica Organica 258
Aziridine Bicicliche con Azoto a Testa di Ponte: Sintesi, Espansione Carbonilativa a beta- Lattami Biciclici 253
High adaptability of the omega loop underlies the substrate-spectrum-extension evolution of a class A β-lactamase, PenL 253
Structural Studies of N-Chloroaziridinecarboxylates by Multinuclear NMR Spectroscopy 252
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 249
Absolute Configuration of 1-Chloro-2,2-bismethoxycarbonylaziridine and Derivatives 249
Enantioselective Lipase-Catalyzed Acetylation of beta-Lactams Precursors of Carbapenem Antibiotics 248
Sintesi asimmetrica biocatalitica di (S)-(-)-Timololo 247
Characterization of 2-Phenylaziridine Derivatives: Tandem MS and MSn Experiments Under Electron Ionization and ESI Conditions 247
Totale 32.718
Categoria #
all - tutte 168.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.017 0 0 0 0 135 190 131 156 316 207 524 358
2022/20233.816 475 427 263 405 400 659 99 324 459 35 126 144
2023/20242.347 96 150 106 247 391 258 406 237 74 84 80 218
2024/20257.753 355 115 187 475 1.424 1.185 480 542 738 241 768 1.243
2025/202614.272 929 747 1.313 1.711 1.980 1.243 1.616 641 1.301 1.320 817 654
2026/20274.493 495 907 1.157 1.676 258 0 0 0 0 0 0 0
Totale 47.786